Patent · US Active

Methods for treating eye disorders

US7465458B2 · kind B2 · utility

8Cited by
35References
11Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 19, 2007
Grant dateDec 16, 2008
Priority date
Expiry dateJul 30, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods of treating an eye disorder. The methods comprise a step of locally administering a Clostridial toxin to the eye of a patient to treat the disorder. The eye disorder may be associated with an inflammation of the eye, including for example, bacterial conjunctivitis, fungal conjunctivitis, viral conjunctivitis, uveitis, keratic precipitates, macular edema, and inflammation response after intra-ocular lens implantation. The Clostridial toxin may be produced by a Clostridial beratti, a Clostridia butyricum, a Clostridial tetani bacterium and/or a Clostridial botulinum.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.